Europe Cosmetic Surgery and Procedure Market Introduction and Overview
According to SPER Market Research, the Europe Cosmetic Surgery and Procedure Market is estimated to reach USD XX billion by 2033 with a CAGR of 5.7%.
The report includes an in-depth analysis of the Europe Cosmetic Surgery and Procedure Market, including market size and trends, product mix, Plantations, and supplier analysis. Medical treatments used in cosmetic surgery and procedures are done to improve a person's look. These procedures cover both surgical and non-surgical options, such as facelifts, liposuction, breast augmentation, Botox injections, and more. The field serves a network of medical specialists, clinics, and support services in addition to patients looking for cosmetic enhancements. In this field, the most important factors are patient happiness, safety, and ethics.
Market Opportunities and Challenges
Due to the rapid improvement of technology in devices and procedures over the past ten years, the market for cosmetic surgery and procedures has experienced exponential growth. The market's expansion is being driven by the public's rising awareness of cosmetic surgery and their desire to feel confident in their own skin.
However, the market dynamics are affected by issues including strict regulatory compliance, safety concerns, high costs, ethical considerations, medical hazards, and the COVID-19 pandemic's impact, which disrupted access and increased safety worries. In this cutthroat and changing market, stakeholders must strike a balance between these elements.
Market Competitive Landscape
The market exhibits a moderate level of fragmentation, with several major players, including Allergan, Alma Lasers Ltd, Bausch Health Companies Inc., Candela Corporation, Cutera Inc., Cynosure Inc., Galderma Laboratories Lp, Ipsen Group, Johnson and Johnson, Merz Pharma, Sientra Inc, Sinclair Pharma, Others.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2019-2033 |
| Base year considered | 2022 |
| Forecast period | 2023-2033 |
| Segments covered | By Type
|
| Regions covered | Belgium, France, Germany, Italy, Netherlands, Russia, Spain, United Kingdom and rest of Europe
|
| Companies Covered | Allergan, Alma Lasers Ltd, Bausch Health Companies Inc., Candela Corporation, Cutera Inc., Cynosure Inc., Galderma Laboratories Lp, Ipsen Group, Johnson and Johnson, Merz Pharma, Sientra Inc, Sinclair Pharma, Others
|
COVID-19 Impact on Europe Cosmetic Surgery and Procedure Market
The market for cosmetic surgery and procedures in Europe was dramatically affected by the COVID-19 pandemic. Lockdowns, travel limitations, and safety worries resulted in the cancellation or postponing of elective surgeries, which temporarily decreased demand. Clinics' operating costs increased as a result of strict sanitary regulations and decreased patient volumes. Consumers' disposable money was also impacted by the economic downturn, which limited their capacity to pay for aesthetic procedures. The desire to improve one's appearance in a post-pandemic environment, however, led to a rise in demand for cosmetic treatments as limitations were loosened. The industry responded by implementing strict safety regulations and telemedicine consultations, ultimately displaying resiliency in the face of difficulty.
Key Target Audience
- Aesthetic Practitioners
- Beauty and Aesthetics Industry Professionals
- Cosmetic Dentists
- Cosmetic Surgery Patients
- Dermatologists
- Medical Insurance Companies
- Medical Spas and Clinics
- Pharmaceutical and Medical Device Companies
- Plastic Surgeons
- Beauty and Fashion Industries
- Others
Our in-depth analysis of the Europe Cosmetic Surgery and Procedure Market includes the following segments:
|
By Type:
|
Breast Augmentation
Breast Lift
Eyelid Surgery
Botulinum Toxin
Chemical Peel
Dermal Fillers
Laser Hair Removal
|
Key Topics Covered in the Report
- Europe Cosmetic Surgery and Procedure Market Size (FY’2023-FY’2033)
- Overview of Europe Cosmetic Surgery and Procedure Market
- Segmentation of Europe Cosmetic Surgery and Procedure Market By Type (Surgical, Non-surgical)
- Statistical Snap of Europe Cosmetic Surgery and Procedure Market
- Expansion Analysis of Europe Cosmetic Surgery and Procedure Market
- Problems and Obstacles in Europe Cosmetic Surgery and Procedure Market
- Competitive Landscape in the Europe Cosmetic Surgery and Procedure Market
- Impact of COVID-19 and Demonetization on Europe Cosmetic Surgery and Procedure Market
- Details on Current Investment in Europe Cosmetic Surgery and Procedure Market
- Competitive Analysis of Europe Cosmetic Surgery and Procedure Market
- Prominent Players in the Europe Cosmetic Surgery and Procedure Market
- SWOT Analysis of Europe Cosmetic Surgery and Procedure Market
- Europe Cosmetic Surgery and Procedure Market Future Outlook and Projections (FY’2023-FY’2033)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. COVID-19 Impacts of the Europe Cosmetic Surgery and Procedure Market
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Europe Cosmetic Surgery and Procedure Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Europe Cosmetic Surgery and Procedure Market
7. Europe Cosmetic Surgery and Procedure Market, By Type (USD Million)
7.1. Europe Cosmetic Surgery and Procedure Market Value Share and Forecast, By Type, 2023-2033
7.2. Surgical
7.2.1. Breast Augmentation
7.2.2. Breast Lift
7.2.3. Eyelid Surgery
7.2.4. Liposuction
7.2.5. Tummy Tuck
7.2.6. Other Surgical Types
7.3. Non-surgical
7.3.1. Botulinum Toxin
7.3.2. Chemical Peel
7.3.3. Dermal Fillers
7.3.4. Laser Hair Removal
7.3.5. Microdermabrasion
7.3.6. Photo-rejuvenation
7.3.7. Other Non-surgical Types
8. Europe Cosmetic Surgery and Procedure Market Forecast, 2019-2033 (USD Million)
8.1. Europe Cosmetic Surgery and Procedure Market Size and Market Share
9. Europe Cosmetic Surgery and Procedure Market, By Type, 2019-2033 (USD Million)
9.1. Europe Cosmetic Surgery and Procedure Market Size and Market Share By Type (2019-2026)
9.2. Europe Cosmetic Surgery and Procedure Market Size and Market Share By Type (2027-2033)
10. Europe Cosmetic Surgery and Procedure Market, By Region, 2019-2033 (USD Million)
10.1. Europe Cosmetic Surgery and Procedure Market Size and Market Share By Region (2019-2026)
10.2. Europe Cosmetic Surgery and Procedure Market Size and Market Share By Region (2027-2033)
10.3. Belgium
10.4. France
10.5. Germany
10.6. Italy
10.7. Netherlands
10.8. Russia
10.9. Spain
10.10. United Kingdom
10.11. Rest of Europe
11. Company Profile
11.1. Allergan
11.1.1. Company details
11.1.2. Financial outlook
11.1.3. Product summary
11.1.4. Recent developments
11.2. Alma Lasers Ltd.
11.2.1. Company details
11.2.2. Financial outlook
11.2.3. Product summary
11.2.4. Recent developments
11.3. Bausch Health Companies Inc.
11.3.1. Company details
11.3.2. Financial outlook
11.3.3. Product summary
11.3.4. Recent developments
11.4. Candela Corporation
11.4.1. Company details
11.4.2. Financial outlook
11.4.3. Product summary
11.4.4. Recent developments
11.5. Cutera Inc.
11.5.1. Company details
11.5.2. Financial outlook
11.5.3. Product summary
11.5.4. Recent developments
11.6. Cynosure Inc.
11.6.1. Company details
11.6.2. Financial outlook
11.6.3. Product summary
11.6.4. Recent developments
11.7. Galderma Laboratories Lp
11.7.1. Company details
11.7.2. Financial outlook
11.7.3. Product summary
11.7.4. Recent developments
11.8. Ipsen Group
11.8.1. Company details
11.8.2. Financial outlook
11.8.3. Product summary
11.8.4. Recent developments
11.9. Johnson and Johnson
11.9.1. Company details
11.9.2. Financial outlook
11.9.3. Product summary
11.9.4. Recent developments
11.10. Merz Pharma
11.10.1. Company details
11.10.2. Financial outlook
11.10.3. Product summary
11.10.4. Recent developments
11.11. Sientra Inc
11.11.1. Company details
11.11.2. Financial outlook
11.11.3. Product summary
11.11.4. Recent developments
11.12. Sinclair Pharma
11.12.1. Company details
11.12.2. Financial outlook
11.12.3. Product summary
11.12.4. Recent developments
11.13. Others
12. List of Abbreviations
13. Reference Links
14. Conclusion
15. Research Scope